Satoshi Honda

National Cerebral and Cardiovascular Center
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (21)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

The Bleeding Academic Research Consortium (BARC) classification was proposed to standardize bleeding endpoint definitions and reports in cardiovascular clinical trials. However, its prognostic value has not been fully validated in East Asian patients with acute myocardial infarction (AMI) who have a higher bleeding risk than Western populations do. We analyzed bleeding events (types 2 or 3) based on the BARC classification in 13,657 patients with AMI (mean age 64.9 ± 12.7 years) from nationwide prospective registries in Japan and Korea. The primary endpoint was all-cause mortality during the 1-year clinical follow-up. During the 1-year follow-up, BARC type 2 or 3 bleeding occurred in 5.5% of the patients (n = 759). Patients who experienced BARC type 2 or 3 bleeding had a significantly higher risk of mortality compared with those without bleeding (hazard ratio [HR] 4.1, 95% confidence interval [CI] 3.4–4.8, p < 0.001). The risk of mortality was higher in BARC type 3 (HR 6.4, 95% CI 5.1–7.9) than in type 2 bleeding (HR 2.4, 95% CI 1.8–3.1). BARC type 2 or 3 bleeding remained significantly associated with increased mortality after adjustment (adjusted HR 1.9, 95% CI 1.5–2.5, p < 0.001). Similar associations with mortality were observed when each BARC classification (type 2 and 3) was analyzed individually. In East Asian patients with AMI, BARC-defined bleeding events were significantly associated with increased mortality. These findings support the adoption of the BARC classification to predict mortality, particularly in East Asian patients with AMI.

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (14)

Misato Chimura

Osaka University

JAPAN
View details

Takahiro Nakashima

Senior Assistant Professor

Kumamoto University Hospital

JAPAN
View details

KYUNG HOON CHO

Clinical professor

Chonnam National University Hospital

SOUTH KOREA
View details

Eliano Pio Navarese

Nicolaus Copernicus University

POLAND
View details

Jeehoon Kang

Seoul National University Hospital

SOUTH KOREA
View details

JUN YAMASHITA

Senior Lecturer

University of Tokyo Hospital

JAPAN
View details

Diana Gorog

Visiting Professor

Imperial College London

UNITED KINGDOM
View details

Masashi Fujino

National Cerebral and Cardiovascular Center

JAPAN
View details

Young-Hoon Jeong

Professor

Chungbuk National University Hospital

SOUTH KOREA
View details

NORMAN HUANGYU LIN

National University Hospital

SINGAPORE
View details

Toshihisa Anzai

Professor

Hokkaido University

JAPAN
View details

Kausik Ray

Professor of Public Health

Imperial College London

UNITED KINGDOM
View details

Kosuke Muto

National Cerebral and Cardiovascular Center

JAPAN
View details

Kota Murai

Medical Doctor

National Cerebral and Cardiovascular Center

JAPAN
View details